[Transitional bladder carcinoma TaG1: role of the EGFr tyrosin kinase activation in the cellular proliferation].

Autor:	Blasco M; Servicio de Urología, Hospital Son Llatzer, Palma de Mallorca, España., Losada J, Fernández Val JF, Sarría R
Jazyk:	Spanish; Castilian
Zdroj:	Medicina clinica [Med Clin (Barc)] 2003 Nov 15; Vol. 121 (17), pp. 641-4.
DOI:	10.1016/s0025-7753(03)74047-0
Abstrakt:	Background and Objective: The purpose of this work was to study if the expression of EGFr oncoprotein and the rate of tumoral cell proliferation in TaG1 transitional bladder carcinoma were related and if this relationship influences the potential aggressivity of the neoplasia. Patients and Method: Twenty-eight patients with TaG1 (non-invasive papillary and well differentiated) transitional bladder carcinoma were randomly selected. EGFr was determined by a semiquantitative immunohistochemical method in three intensity levels. The proliferative tumoral cell activity was determined by the PCNA index, that is, the relation between the total number of tumor cells and the number of tumor cells with nuclear PCNA-immunoreactivity expressed in percentage. Results: The rate of cellular tumour proliferation (PCNA index) was significantly higher in those tumors with EGFr's greater expression (p=0.005). The EGFr expression was associated with tumor recurrence (p=0.012). Conclusions: The major expression of EGFr oncoprotein in tumours with higher rate of cell proliferation indicates that it may be influenced by the activity of such oncoprotein. The binding of a ligand to the EGFr leads to intracellular tumor proliferation, hence possibly favouring a more aggressive biological behavior.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu